LicianPro

INSMED Inc ·

INSM 8-K 2026-10-05

INSMED Inc (INSM) 8-K dated 2026-10-05 — accession 0001140361-26-038529.

INSMED Inc (INSM) is a biotechnology company listed on US.

INSMED Inc filed a 8-K on 2026-10-05. Accession 0001140361-26-038529.

This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.

Latest reported INSM revenue for 2025-12-31 was $606.4M. Net income was -$1.28B. Revenue was up 66.7% from 2024-12-31 to 2025-12-31. INSM currently screens at market cap $20.42B.

Not investment advice. The INSM SEC hub lists recent forms. The stock page is the research view.

Open on SEC EDGAR

These filings as JSON? API free 100/day

Lician Pro $19.99/mo or $149/yr